Oxipurinol
 | |
| Names | |
|---|---|
| Preferred IUPAC name
1,2-Dihydropyrazolo[4,3-e]pyrimidine-4,6-dione | |
| Systematic IUPAC name
1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione | |
| Other names
1H,2H,5H-pyrazolo[3,4-d]pyrimidine-4,6-dione Alloxanthine | |
| Identifiers | |
| 3D model (JSmol) |
|
| 139956 | |
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.017.792 |
| EC Number | 219-570-9 |
| KEGG | |
| MeSH | Oxypurinol |
| PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C5H4N4O2 | |
| Molar mass | 152.11086 |
| Appearance | white crystals |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Oxipurinol (INN, or oxypurinol USAN) is an inhibitor of xanthine oxidase. It is an active metabolite of allopurinol and it is cleared renally. In cases of renal disease, this metabolite will accumulate to toxic levels. By inhibiting xanthine oxidase, it reduces uric acid production. High serum uric acid levels may result in gout, kidney stones, and other medical conditions.
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.